4//SEC Filing
ACCESS PHARMACEUTICALS INC 4
Accession 0000318306-14-000002
$ABEOCIK 0000318306operating
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 5:27 PM ET
Size
8.0 KB
Accession
0000318306-14-000002
Insider Transaction Report
Form 4
Jeffrey B Davis
DirectorChief Executive Officer
Transactions
- Award
Stock option (right to buy)
2014-03-07$0.37/sh+500,000$185,000→ 525,000 totalExercise: $0.37From: 2014-03-07Exp: 2024-03-07→ Common stock (500,000 underlying) - Award
Stock option (right to buy)
2014-03-07$0.37/sh+1,500,000$555,000→ 2,025,000 totalExercise: $0.37From: 2015-03-07Exp: 2024-03-07→ Common stock (1,500,000 underlying)
Footnotes (1)
- [F1]500,000 stock options vest on each 03/07/2015, 03/07/2016 and 03/07/2017. All options are subject to accelerated vesting as follows: 50% vest upon the market capitalization of the company reaching $100 million and 100% vest upon the market capitalization of the company reaching $200 million.
Documents
Issuer
ACCESS PHARMACEUTICALS INC
CIK 0000318306
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000318306
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 5:27 PM ET
- Size
- 8.0 KB